The Feasibility, Safety, and Early Response of Tisagenlecleucel Therapy for Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Gocho, Yoshihiro [1 ]
Sakaguchi, Hirotoshi [1 ]
Iguchi, Akihiro [1 ]
Nishimura, Nao [2 ]
Uchiyama, Toru [3 ]
Deguchi, Takao [1 ]
Kato, Motohiro [1 ]
Tomizawa, Daisuke [1 ]
Onodera, Masafumi [3 ]
Matsumoto, Kimikazu [1 ]
机构：
[1] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan
[2] Natl Ctr Child Hlth & Dev, Dept Crit Care & Anesthesia, Tokyo, Japan
[3] Natl Ctr Child Hlth & Dev, Dept Human Genet, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS1-16
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Brexucabtagene Autoleucel for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 60 and Above
    Muhsen, Ibrahim
    Advani, Anjali S.
    Roloff, Gregory W.
    Jeyakumar, Nikeshan
    Miller, Katharine
    Zhang, Amy
    Sutherland, Katherine C.
    Grunwald, Michael R.
    Kota, Vamsi K.
    Boccucci, Jacob
    Ulrickson, Matthew
    Sasine, Joshua
    Aldoss, Ibrahim
    Othman, Tamer
    Vasu, Sumithira
    Reshef, Ran
    Luskin, Marlise R.
    Chen, Evan C.
    Lin, Chenyu
    Langston, Amelia
    Cassaday, Ryan D.
    Kopmar, Noam E.
    Tsai, Stephanie B.
    O'Connor, Timothy E.
    Hilal, Talal
    Faramand, Rawan
    Park, Jae H.
    Valtis, Yannis K.
    Solh, Melhem M.
    Bezerra, Evandro
    Leonard, Jessica T.
    Dekker, Simone E.
    Majhail, Navneet
    Battiwalla, Minoo
    Malik, Shahbaz A.
    Mathews, John
    Shaughnessy, Paul
    Mountjoy, Luke
    Hoeg, Rasmus T.
    Oliai, Caspian H.
    Gupta, Vishal
    Koura, Divya
    Dykes, Kaitlyn C.
    Logan, Aaron C.
    Kumaran, Muthu, V
    Stock, Wendy
    Schwartz, Marc
    Bachanova, Veronika
    Tracy, Sean
    O'Dwyer, Kristen M.
    BLOOD, 2024, 144 : 523 - 526
  • [42] Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
    Franco Locatelli
    James A. Whitlock
    Christina Peters
    Christiane Chen-Santel
    Victoria Chia
    Robyn M. Dennis
    Kenneth M. Heym
    Aaron J. Katz
    Michael A. Kelsh
    Richard Sposto
    Huakang Tu
    Catherine A. Tuglus
    Anupam Verma
    Luciana Vinti
    Jennifer J. Wilkes
    Nathalya Zubarovskaja
    Gerhard Zugmaier
    Arend von Stackelberg
    Weili Sun
    Leukemia, 2020, 34 : 2473 - 2478
  • [43] Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    Whitlock, James A.
    Peters, Christina
    Chen-Santel, Christiane
    Chia, Victoria
    Dennis, Robyn M.
    Heym, Kenneth M.
    Katz, Aaron J.
    Kelsh, Michael A.
    Sposto, Richard
    Tu, Huakang
    Tuglus, Catherine A.
    Verma, Anupam
    Vinti, Luciana
    Wilkes, Jennifer J.
    Zubarovskaja, Nathalya
    Zugmaier, Gerhard
    von Stackelberg, Arend
    Sun, Weili
    LEUKEMIA, 2020, 34 (09) : 2473 - 2478
  • [44] Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
    Laetsch, Theodore W.
    Maude, Shannon L.
    Balduzzi, Adriana
    Rives, Susana
    Bittencourt, Henrique
    Boyer, Michael W.
    Buechner, Jochen
    De Moerloose, Barbara
    Qayed, Muna
    Phillips, Christine L.
    Pulsipher, Michael A.
    Hiramatsu, Hidefumi
    Tiwari, Ranjan
    Grupp, Stephan A.
    LEUKEMIA, 2022, 36 (06) : 1508 - 1515
  • [45] The Efficacy of Chidamide Maintenance Therapy after CAR-T Therapy for Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
    Zhang, Xian
    Huang, Lefu
    Zhang, Gailing
    Su, Yunchao
    Hu, Xiaona
    Xia, Shulian
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2022, 140 : 8884 - 8885
  • [46] Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia
    Thota, Swapna
    Advani, Anjali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (05) : 425 - 434
  • [47] Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
    Darcin, Tahir
    Yigenoglu, Tugce Nur
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Merdin, Alparslan
    Yildiz, Jale
    Ulu, Bahar Uncu
    Tetik, Aysegul
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S192 - S193
  • [48] Tisagenlecleucel Approved in Relapsed/Refractory Large B-Cell Lymphoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (06) : 397 - 397
  • [49] Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
    Theodore W. Laetsch
    Shannon L. Maude
    Adriana Balduzzi
    Susana Rives
    Henrique Bittencourt
    Michael W. Boyer
    Jochen Buechner
    Barbara De Moerloose
    Muna Qayed
    Christine L. Phillips
    Michael A. Pulsipher
    Hidefumi Hiramatsu
    Ranjan Tiwari
    Stephan A. Grupp
    Leukemia, 2022, 36 : 1508 - 1515
  • [50] Immunotherapy in pediatric B-cell acute lymphoblastic leukemia
    Wyatt, Kirk D.
    Bram, Richard J.
    HUMAN IMMUNOLOGY, 2019, 80 (06) : 400 - 408
12345